Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

2(33.3%)

Phase 3

1(16.7%)

Phase 4

1(16.7%)

Phase 1

1(16.7%)

Phase 2

1(16.7%)

6Total

N/A(2)

Phase 3(1)

Phase 4(1)

Phase 1(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07243704Phase 3Not Yet Recruiting

Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage

Role: collaborator

NCT05836831Phase 4Recruiting

Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage

Role: collaborator

NCT07196293Not ApplicableCompleted

A Comparison Between Protemp and Flowable Light Cure Composite Material for Creating Optimal Gingival Emergence Profile Around Implant

Role: lead

NCT05700695Phase 1Completed

Intravenous BCAA for HE in ACLF (BCAA-HE-ACLF)

Role: collaborator

NCT06527105Not ApplicableRecruiting

Impact of Sleep Quality on Outcomes After Cardiac Surgery

Role: lead

NCT05144100Phase 2Not Yet Recruiting

Surgery Vs Chemoradiation for Oropharyngeal Cancer- A Phase II/III Integrated Design Randomized Control Trial

Role: collaborator

NCT02420067Recruiting

Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients

Role: collaborator

NCT01095146Unknown

New Candidate Criteria for Diagnosis of Macrophage Activation Syndrome

Role: lead

NCT01032863Completed

Association Between Hypermobility and Chronic Musculoskeletal Pain

Role: lead

All 9 trials loaded